TNNT2 and atrial fibrillation: In conclusion, our study shows a strong value of hs-cTnT when added to the CHA2DS2-VASc score These findings highlight the promise of a biomarker-enhanced CHA2DS2-VASc score for individualized risk assessment in AF patients at intermediate risk.